Skip to main content
. 2019 Oct 18;10:1232. doi: 10.3389/fphar.2019.01232

Figure 2.

Figure 2

Schematic representation of dasatinib mediated mechanisms that could interfere with HIV-1 infection. (1) Inhibition of SAMHD1 phosphorylation, maintaining its intrinsic antiviral activity; (2) inhibition of mass activation, establishment of viral reservoirs, depletion of CD4+ T cells, and reduction of infected cells that carry the pro-viral DNA of HIV-1; (3) inhibition of inflammation and reduction in senescence; (4) potentiation of cytotoxic activity mediated by memory NK cells and T lymphocytes against HIV; (5) increase of immune effector cells such as cytotoxic LGLs by reducing levels of Tregs and M-MDSC, which are suppressor cells. Adapted from Coiras et al. (2017).